Shuwen Biotech
PrivateLast Round
Series C
Extension
Jul 8, 2025
Total Funding Raised
$29.39M
Company Overview
Shuwen Biotech operates in Healthcare & Life Sciences and is based in Deqing. Its latest recorded funding round was a Series C Extension round in July 2025.
Shuwen Biotech is a diagnostics company that develops and commercializes novel solutions for healthcare, specializing in oncology, women's health, and critical care.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shuwen Biotech Comparables
Compare Shuwen Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| New Genetron Holding Limited | 79% | |
| Agendia | 77% | |
| Amoy Diagnostics Co., Ltd. | 76% |
For institutional investors. Book with your work email.
Shuwen Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Jul 8, 2025 | ||||
| Series B | Sep 9, 2021 |
For institutional investors. Book with your work email.
Shuwen Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wuxi Capital Group | Series B |
| YuanBio Venture Capital | Series C Extension |
| Anyuan Fund | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 14, 2025
Grew 25% QoQ, from 12 to 15 employees.
- Jul 8, 2025
$14M round led by YuanBio Venture Capital.
For institutional investors. Book with your work email.
Shuwen Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shuwen Biotech's valuation, stock price, and market status.
Is Shuwen Biotech a public or private company?
Shuwen Biotech is a private company.
What is the current stock price of Shuwen Biotech?
Shuwen Biotech is a private company, so its shares have no public market price. Caplight tracks Shuwen Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shuwen Biotech worth (valuation)?
Valuation information for Shuwen Biotech is not publicly available.
Can I buy Shuwen Biotech stock?
Shuwen Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shuwen Biotech's last funding round?
Shuwen Biotech's most recent funding round was Series C Extension on July 8, 2025.
Who are the main investors in Shuwen Biotech?
Key investors in Shuwen Biotech include Wuxi Capital Group.
Will Shuwen Biotech IPO soon?
No public IPO plans have been announced for Shuwen Biotech.
How can I track Shuwen Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Shuwen Biotech's shares on secondary markets.